These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 21170080
1. Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma. Wang K, Liu CT, Wu YH, Feng YL, Bai HL, Ma ES, Wen FQ. Acta Pharmacol Sin; 2011 Jan; 32(1):126-32. PubMed ID: 21170080 [Abstract] [Full Text] [Related]
2. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. Kelly MM, O'Connor TM, Leigh R, Otis J, Gwozd C, Gauvreau GM, Gauldie J, O'Byrne PM. J Allergy Clin Immunol; 2010 Feb; 125(2):349-356.e13. PubMed ID: 19969339 [Abstract] [Full Text] [Related]
3. The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics. Capraz F, Kunter E, Cermik H, Ilvan A, Pocan S. Lung; 2007 Feb; 185(2):89-96. PubMed ID: 17393237 [Abstract] [Full Text] [Related]
4. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Aalbers R, Boorsma M, van der Woude HJ, Jonkers RE. Respir Res; 2010 May 28; 11(1):66. PubMed ID: 20509942 [Abstract] [Full Text] [Related]
5. Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma. Wang K, Liu CT, Wu YH, Feng YL, Bai HL. Adv Ther; 2008 Apr 28; 25(4):342-54. PubMed ID: 18421428 [Abstract] [Full Text] [Related]
6. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation. Takeyama K, Kondo M, Tagaya E, Kirishi S, Ishii M, Ochiai K, Isono K, Tamaoki J. Allergy Asthma Proc; 2014 Apr 28; 35(2):141-7. PubMed ID: 24717791 [Abstract] [Full Text] [Related]
7. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. Pavord ID, Jeffery PK, Qiu Y, Zhu J, Parker D, Carlsheimer A, Naya I, Barnes NC. J Allergy Clin Immunol; 2009 May 28; 123(5):1083-9, 1089.e1-7. PubMed ID: 19368965 [Abstract] [Full Text] [Related]
8. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma. Hoshino M, Ohtawa J. Respirology; 2012 May 28; 17(4):639-46. PubMed ID: 22248352 [Abstract] [Full Text] [Related]
9. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study. Price D, Haughney J, Lloyd A, Hutchinson J, Plumb J. Curr Med Res Opin; 2004 Oct 28; 20(10):1671-9. PubMed ID: 15462701 [Abstract] [Full Text] [Related]
10. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results. Atienza T, Aquino T, Fernández M, Boonsawat W, Kawai M, Kudo T, Ekelund J, Ivanov S, Carlsson LG. Respirology; 2013 Feb 28; 18(2):354-63. PubMed ID: 23126237 [Abstract] [Full Text] [Related]
11. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. Dahlén B, Lantz AS, Ihre E, Skedinger M, Henriksson E, Jörgensen L, Ekström T, Dahlén SE, Larsson K. Eur Respir J; 2009 Apr 28; 33(4):747-53. PubMed ID: 19129280 [Abstract] [Full Text] [Related]
12. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L. Drugs; 2006 Apr 28; 66(17):2235-54. PubMed ID: 17137405 [Abstract] [Full Text] [Related]
13. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. Bodzenta-Lukaszyk A, Buhl R, Balint B, Lomax M, Spooner K, Dissanayake S. J Asthma; 2012 Dec 28; 49(10):1060-70. PubMed ID: 23102189 [Abstract] [Full Text] [Related]
14. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. FitzGerald JM, Sears MR, Boulet LP, Becker AB, McIvor AR, Ernst P, Smiljanic-Georgijev NM, Lee JS, Canadian Investigators. Can Respir J; 2003 Dec 28; 10(8):427-34. PubMed ID: 14679407 [Abstract] [Full Text] [Related]
15. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, Ekström T, Selroos O. Curr Med Res Opin; 2006 May 28; 22(5):809-21. PubMed ID: 16709303 [Abstract] [Full Text] [Related]
16. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma. Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K. Pulm Pharmacol Ther; 2014 Feb 28; 27(1):52-6. PubMed ID: 23583566 [Abstract] [Full Text] [Related]
17. Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts. Todorova L, Gürcan E, Westergren-Thorsson G, Miller-Larsson A. Respir Med; 2009 Nov 28; 103(11):1755-63. PubMed ID: 19375904 [Abstract] [Full Text] [Related]
18. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Tal A, Simon G, Vermeulen JH, Petru V, Cobos N, Everard ML, de Boeck K. Pediatr Pulmonol; 2002 Nov 28; 34(5):342-50. PubMed ID: 12357478 [Abstract] [Full Text] [Related]
19. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Wilson SJ, Wallin A, Della-Cioppa G, Sandström T, Holgate ST. Am J Respir Crit Care Med; 2001 Sep 15; 164(6):1047-52. PubMed ID: 11587995 [Abstract] [Full Text] [Related]
20. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. Aalbers R. Clin Drug Investig; 2010 Sep 15; 30(7):439-51. PubMed ID: 20528000 [Abstract] [Full Text] [Related] Page: [Next] [New Search]